FINV Q4 2025 Earnings EPS Reported at 172 Stock Declines Amid Incomplete Disclosure PM Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Pricing and Volume Mix Pasithea Therapeutics Corp KTTA Q1 2026 Earnings Significant EPS Beat Despite Zero Revenue Kiniksa Pharmaceuticals Q1 2026 Earnings EPS Surprises by 315 Despite Stock Decline First Advantage Corporation FA Q1 2026 Earnings EPS Beats Estimates by 216 Despite Stock Decline Nike NKE Q1 2026 Earnings EPS Surges Past Estimates with 2289 Beat